My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Johnson & Johnson (NY:JNJ)

210.01 +3.47 (+1.68%)

Official Closing Price Updated: 7:00 PM EST, Dec 11, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

February 03, 2025

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

Via MarketBeat

Is Johnson & Johnson Stock a Buy? ↗

February 02, 2025

Via The Motley Fool

Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around? ↗

February 01, 2025

Via The Motley Fool

Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock? ↗

February 01, 2025

Via The Motley Fool

The Dogs Of The Dow 2025 ↗

January 31, 2025

The Dogs of the Dow is an investing strategy well-known to retail and institutional investors.

Via Talk Markets

Topics Stocks Stocks / Equities

Johnson & Johnson's Options Frenzy: What You Need to Know ↗

January 30, 2025

Via Benzinga

Where Johnson & Johnson Stands With Analysts ↗

January 23, 2025

Via Benzinga

Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates

January 31, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 5.3% year on year to $22.52 billion. Its non-GAAP profit of $2.04 per...

Via StockStory

Topics Artificial Intelligence Intellectual Property

RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders ↗

January 29, 2025

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the American people.

Via Benzinga

Topics Government

Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 29, 2025

Via Benzinga

Marjorie Taylor Greene Loads Up On Meta, Amazon, Tesla, Nvidia And Other Stocks As Donald Trump's New Equations With Big Tech Leaders Sets Stage For Growth: What Is At Stake? ↗

January 29, 2025

U.S. House Representative Marjorie Taylor Greene has disclosed new trades as Donald Trump's equations evolves with Big Tech leaders.

Via Benzinga

Topics Government

Georgia Rep. Marjorie Taylor Greene Bought Up to $45K Worth of Johnson & Johnson Stock ↗

January 28, 2025

Via Benzinga

3 Stocks Upgraded by Bank of America – Here's Why They're Bullish

January 28, 2025

Bank of America analysts have recently shifted their views on these three stocks, leaving investors with a few points to consider.

Via MarketBeat

McDonald's To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

January 28, 2025

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), Shutterstock, Inc. (NYSE - SSTK)

January 27, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 27, 2025

Via Benzinga

Why Traders Are Buying the Dip on Johnson & Johnson Stock

January 25, 2025

Shares of Johnson & Johnson stock have declined by 11.5% in the quarter, and markets are calling for a bottom and rally here.

Via MarketBeat

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024 ↗

January 25, 2025

Via The Motley Fool

Topics Stocks

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

January 24, 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Via MarketBeat

5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025 ↗

January 24, 2025

Five magnificent income stocks -- sporting an average yield of 4.26% -- can pad investors' pocketbooks in the new year (and well beyond).

Via The Motley Fool

Stocks Going Ex Dividend In February 2025 ↗

January 24, 2025

This article features a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors

Via Talk Markets

Topics Stocks / Equities

Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring? ↗

January 23, 2025

Via The Motley Fool

Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst ↗

January 23, 2025

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Via Benzinga

This Is 1 of the Healthiest High-Yielding Dividend Stocks You'll Find ↗

January 23, 2025

Via The Motley Fool

Earnings Picture Remains Strong: A Closer Look ↗

January 22, 2025

Total earnings for the 62 S&P 500 companies that have reported results are up +19.6% from the same period last year on +8.4% higher revenues, with 82.3% beating EPS estimates and 69.4% beating revenue...

Via Talk Markets

Topics Stocks Stocks / Equities

S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run ↗

January 22, 2025

Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks.

Via Benzinga

Topics Artificial Intelligence Government Stocks

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst ↗

January 22, 2025

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, despite investor concerns over M&A and deals.

Via Benzinga

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript ↗

January 22, 2025

JNJ earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday? ↗

January 22, 2025

Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp.

Via Benzinga

Topics Artificial Intelligence Government

Johnson & Johnson Q4 Earnings And Revenues Top Estimates ↗

January 22, 2025

Johnson & Johnson came out with quarterly earnings of $2.04 per share.

Via Talk Markets

Topics Stocks / Equities

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.